Compound ID | 563
Class: Fluoroquinolone
Spectrum of activity: | Gram-negative |
Details of activity: | Activity against MRSA and CAP |
Institute where first reported: | Daiichi Pharmaceutical; Pfizer |
Year first mentioned: | 2001 |
Highest developmental phase: | Phase 1 |
Development status: | Inactive |
Reason Dropped: | Pfizer and Daiichi announced discontinuation of this antibiotic in 2004 after analysis of Phase I trial data |
Chemical structure(s): | |||||||||||
|
|
External links: | |
PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/5271826 |
Guide to Pharmacology: | DK-507k |
Citation: | https://journals.asm.org/doi/10.1128/aac.47.12.3750-3759.2003 |